A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24590025.
- Also identified by DOI 10.1378/chest.13-1502.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy findings were consistent with drug-induced lung injury. Clinicians should be aware of this significant adverse event with this drug class.
Medical subject headings
- Acute Coronary Syndrome
- Adenosine
- Hemoptysis
- Pneumonia